Drug Shortage Report for ACT-HIB

Last updated on 2023-07-28 History
Report ID 199936
Drug Identification Number 01959034
Brand name ACT-HIB
Common or Proper name Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate)
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP
Strength(s) 30MCG 10MCG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials
ATC code J07AG
ATC description BACTERIAL VACCINES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-07-20
Estimated end date 2023-08-11
Actual end date 2023-07-28
Shortage status Resolved
Updated date 2023-07-28
Company comments This shortage is a result of two factors - delay in shipping of the drug & an increase in demand
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2023-07-28 French Compare
v3 2023-07-28 English Compare
v2 2023-07-24 French Compare
v1 2023-07-24 English Compare

Showing 1 to 4 of 4